Abstract Poly (ethylene glycol)(PEG) is a nontoxic, hydrophilic polymer that is often covalently attached to proteins, drugs, tissues, or materials; a procedure commonly referred …
In this issue of ACS Nano, Chen et al. provide in vitro and in vivo evidence for monoclonal anti-poly (ethylene glycol)(anti-PEG) antibody-triggered, complement terminal complex …
PEGylation technique is currently considered the gold standard approach to provide a long and safe circulation of drugs. Although this is the accepted dogma, various clinical reports …
Pharmacokinetics, biodistribution, and biological activity are key parameters that determine the success or failure of therapeutics. Many developments intended to improve their in vivo …
G Karpel-Massler, D Ramani, C Shu, ME Halatsch… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Cancer cells display a variety of global metabolic changes, which aside from the glycolytic pathway largely involve amino acid metabolism. To ensure aggressive growth, tumor cells …
HD Swanson, JC Panetta, PJ Barker… - Blood, The Journal …, 2020 - ashpublications.org
Asparaginase is a critical component of acute lymphoblastic leukemia (ALL) therapy. Available asparaginase products in the United States include pegaspargase (Oncaspar) …
A total of 548 patients (age range: 1–22 years, 60.4% Hispanic, 55.8% male) diagnosed with acute lymphoblastic leukemia were reviewed for pegaspargase-associated hypersensitivity …
S Liu, C Gao, Y Wu, W Lin, J Li, T Xue, L Wang… - …, 2021 - Taylor & Francis
Aim: To evaluate the associations between human leukocyte antigen (HLA)-DRB1 variants and the rs6021191 variant in nuclear factor of activated T cells 2 (NFATC2) with PEG …
EK Browne, C Moore, A Sykes, Z Lu… - Journal of Pediatric …, 2018 - journals.sagepub.com
Background: Asparaginase poses a substantial risk for hypersensitivity reactions during and after administration; however, these reactions vary by asparaginase formulation and …